U.S. Rep. Vern Buchanan (R-FL) on May 8 sponsored a bipartisan bill to increase and facilitate close coordination between the United States and Israel on new and improved healthcare technologies.
The Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging (MIRACLE) Medical Technology Act, H.R. 8299, would promote research and development between the U.S. and Israel and support innovation hubs to hasten the development and commercialization of new and emerging health technologies, according to a bill summary provided by Rep. Buchanan’s staff.
“Similar to the United States, Israel is a leading hub for new and innovative health-related technology,” Rep. Buchanan said. “I am pleased to introduce this important bipartisan legislation… to help foster and build stronger ties in health care between the United States and our greatest ally in the Middle East, Israel.”
If enacted, H.R. 8299 also would establish health Internet protocol protections for biological products shared between the countries, facilitate best practices to bolster healthcare systems, and improve telemedicine infrastructure between the two countries, the summary says.
Additionally, the bill would increase disease prevention initiatives, promote exchange programs and training initiatives, and establish a U.S.-Israel Health Care Collaboration Center, states the summary.
The bill is supported by the American Israel Public Affairs Committee, the Combat Antisemitism Movement, the Conference of Presidents of Major American Jewish Organizations, and the Jewish Federations.
“I am proud to work with Congressman Buchanan on this effort to strengthen collaboration between the United States and Israel in the healthcare space,” said U.S. Rep. Darren Soto (D-FL), the bill’s lead original cosponsor. “I look forward to working with my colleagues on both sides of the aisle to move this innovative proposal forward.”